Clofazimine: History and Perspectives
The review analyses 47 publications that follow the pathway of clofazimine from its discovery to recognition as a Group B drug for treatment of multiple drug resistant tuberculosis. It describes its mechanism of action and effects on Mycobacterium tuberculosis, pharmacokinetics, and safety parameter...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEW TERRA Publishing House
2021-06-01
|
Series: | Tuberkulez i Bolezni Lëgkih |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/1541 |